This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Cold, Cough and Sore Throat Remedies Market

Find Out How Cold, Cough and Sore Throat Remedies Are Helping People Suffering From Infectious Diseases To Lead A Better Life!

Cold, Cough and Sore Throat Remedies Market by Drug, Doses, Distribution Channel & Region - Forecast 2022 – 2032

Cold, Cough and Sore Throat Remedies Market Outlook (2022-2032)

[250 Pages Report] The global cold, cough and sore throat remedies market is expected to enjoy a valuation of US$ 39.9 Bn by the end of the year 2022, and further expand at a CAGR of 0.6% between 2022 and 2032, reaching a valuation of ~US$ 37.7 Bn by 2032.

Rising prevalence of infectious diseases, growing health awareness among people and increasing consumption of various medicines like antihistamines, antibiotics, and bronchodilators are some of the key factors driving growth in the global cold, cough and sore throat remedies market.

Based on doses, oral syrups segment dominated the global cold, cough and sore throat market with a share of about 33.3% in 2021 and the trend is likely to continue during the forecast period.

Attribute

Key Statistics

Cold, Cough and Sore Throat Remedies Market Base Value (2021)

US$ 38.7 Bn

Estimated Market Size (2022)

US$ 39.9 Bn

Projected Market Size (2032)

US$ 37.7 Bn

Valued-based CAGR (2022-2032)

0.6%

Market Share of Top 5 Countries

61.7%

Over the years, there has been a rapid surge in disease like upper respiratory tract infection, common cold, and influenza. This has prompted people to spend vigorously on purchasing various cold, cough and sore throat remedies, thereby accelerating growth of the market.

According to a paper published in The Lancet, the total incidence of upper respiratory tract infections reached 17·2 billion in 2019 globally. Upper respiratory tract infection (URI), sometimes referred to as the common cold, is a severe, self-limiting viral infection of the upper airways that may also affect the lower respiratory tract. Every adult is familiar with the defining symptom complex of rhinorrhea, nasal congestion, and painful or scratchy throat. In order to relieve symptoms and treat these medical conditions, people are consuming drugs like antihistamines, decongestants, and antibiotics. This will continue to bolster the growth of cold, cough and sore throat remedies market during the forecast period.

The global cold, cough and sore throat remedies market formed approximately 77.3% of the overall ~US$ 50.0 Bn global antibiotics market in 2021.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Cold, Cough and Sore Throat Remedies Market from 2015 to 2021 Vs Market Outlook for 2022 to 2032

The global cold, cough and sore throat remedies market is anticipated to grow at 0.6% CAGR between 2022 and 2032, in comparison to 3.0% CAGR registered during the historical period of 2015 to 2021,

Rising prevalence of infectious diseases, the advent of the global COVID-19 pandemic and development of new cold, cough and sore throat remedies are some of the key factors driving growth in the global market.

Colds are frequently contracted because many viruses that cause colds have several serotypes and some do not establish long-lasting immunity after infection. Human coronaviruses (HCoVs), parainfluenza viruses (PIVs), and respiratory syncytial virus (RSV), are cold viruses that do not induce long-lasting immunity. Influenza viruses, enteroviruses rhinoviruses, and adenoviruses are examples of cold viruses that have several serotypes but after infection creates long-lasting serotype-specific immunity.

Currently, no proper antiviral medications are available that can effectively treat the common cold. Although a variety of drugs may be used to treat symptoms, there is little scientific evidence to back up the use of symptomatic therapies in children. A significant placebo effect may indicate that some therapies are effective for the common cold because it is a self-limiting sickness with subjective symptomatology.

First-generation antihistamines (such as chlorpheniramine) have been demonstrated to offer modest symptom alleviation in adults with colds, with reductions in sneezing, nasal discharge, nose blowing, and duration of symptoms. This is likely because of the anticholinergic actions of these drugs.

The frequent symptoms for which people seek medical help in both primary care and specialised settings include cough. Most often, acute respiratory infections, post-viral epithelium damage, or enhanced cough receptor sensitivity are the causes of cough in children; serious illnesses are quite uncommon.

Thus, rising consumption of cold, cough and sore throat remedies like antibiotics and antihistamines for relieving various symptoms is expected to provide a strong impetus to market growth during the forecast period.

Similarly, increasing government initiatives to reduce global burden of diseases like common cold and cough along with easy availability of OTC medicines will further boost the demand for cold, cough and sore remedies during the next ten years.

Cold, Cough and Sore Throat Remedies Market Download Report Brochure

What are the Recent Trends Impacting the Cold, Cough and Sore Throat Remedies Market?

“Growing Awareness About the Benefits of Cold, Cough and Sore Throat Remedies Driving Market Growth”

Persistent cold or cough causes more troubles to quality of a patient’s life and interrupts his/her daily activities. As a result, people are looking for various effective medications that can help them to relieve symptoms and treat these conditions.

Rising awareness about cold, cough and sore throat remedies and their effectiveness will therefore continue to act as a catalyst triggering market growth during the forecast period.

A wide range of cold, cough and sore throat medications are available in the market for the treatment of cold, cough, sore throat and other allergies.

Opioid derivatives are frequently marketed as cough medicines (antitussives) to stop frequent coughing by preventing cough reflux from the medulla in the brain stem. Dihydrocodeine, Dextromethorphan, codeine, and pholcodine, are some of the available common medicines for cold, cough and sore throat remedies. These may be offered for sale as pills, capsules, medicated lozenges, syrups, or other forms.

Although the benefits of these agents are very weakly supported by research, consumer demand for these goods might be substantial, presenting an opportunity for the market players to increase their product accessibility.

There are two types of medications approved for the treatment of productive coughs: expectorants (protussives) and mucolytics. These medications, like antitussives, are available as syrups, medicated lozenges, tablets, or capsules. Expectorants, like guaifenesin, encourage mucus secretion in the airways and lessen adhesion, which increases the effectiveness of coughing to clear mucus.

Mucolytics, such as bromhexine, work to thin the mucus to make clearance easier. In order to help manage coughs, mucolytics and expectorants are often sold in combination formulations.

With the availability of several marketed solutions, the demand for cold, cough and sore throat remedies is expected to be bolstered with rising disease burden on a global scale. This factor presents the market entrants, as well as the established industry players with lucrative opportunities to expand their revenue.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Growth of the Cold, Cough and Sore Throat Remedies Market?

Suppressing the cough has no benefit for the majority of disorders associated with the symptom. Narcotic addiction and the lack of the protective cough reflex, which leads to mucus retention and the possibility of superinfection, are some of the drawbacks of many of the available cough suppressants.

Additionally, the prescribing of drugs that lack strong evidence or indications, and are not appropriate for the patient's symptoms, are contraindicated, or are given in the wrong doses, is also restraining the market growth.

With the misuse of available OTC medications for cold, cough and sore throat, as well as the lack of standard prescription patterns for a variable range of disease indications, the market for cold, cough and sore throat remedies is set to experience restricted growth over the forecast years.

Country-wise Insights

What Makes the U.S. a Prominent Market for Cold, Cough and Sore Throat Remedies?

“Rising Incidence of Various Types of Allergies is Bolstering Market Growth in the U.S.”

The U.S. dominated the North American cold, cough and sore throat remedies market with a total market share of about 95.4% in 2021 and is expected to continue to experience the same growth throughout the forecast period.

Advances in clinical care settings, availability of health schemes for children and adults for the management of cold, cough and sore throat, high levels of health awareness among people, and large presence of some of the leading pharmaceutical giants are driving growth in the U.S. cold, cough and sore throat remedies market.

Similarly, surge in cases of allergies and other medical conditions and awareness regarding the management of symptoms of cold will further push the demand for cold, cough and sore throat remedies.

As per the Asthma and Allergy Foundation of America (AAFA), over 50 million Americans experience various types of allergies each year. In order to treat them, they consume medicines like antibiotics, antihistamines, expectorants, and decongestants.

What is the Outlook Cold, Cough and Sore Throat Remedies Market in Germany?

“Increasing Spending on Cold, Cough and Sore Throat Medicines Fuelling Market Growth in Germany”

As per FMI, the cold, cough and sore throat remedies market in Germany is set to exhibit a CAGR of nearly 0.1% during the forecast period. Growth in the market is driven by rising prevalence of common cold, increasing consumer spending on medications, and presence of well-established players within the region.

Moreover, with a lucrative supply chain, compared to the demand, the market for cold, cough and sore throat is expected to display high traction in terms of overall revenue, within the country.

What Makes China a Highly Lucrative Market for Cold, Cough and Sore Throat Remedies?

“Easy Availability of Cold, Cough and Sore Throat Drugs at Lower Prices Fuelling Demand in China”

China held approximately 21.7% share in the global cold cough and sore throat remedies market in 2021 and is projected to display growth at a lucrative CAGR of 1.0% during the forecast period. Growth in China’s cold, cough and sore throat remedies market is driven by rising geriatric population, rise in the number of people suffering from acute and chronic cough, favourable government support, and easy availability of OTC medications at much lower prices,

The Panel of Chinese Thoracic Society (CTS) Asthma Consortium published the first version of the Chinese Guidelines for Diagnosis and Treatment of Cough in 2005 (revised 2009) to standardise the diagnosis and treatment of acute and chronic cough, thereby offering advice for clinical practice. This is playing a key role in pushing the demand for cold, cough and sore throat remedies in the country.

With expert recommendations on the indications of prescribing remedies by physicians for cold, cough and sore throat, standardized guidelines within the country are set to propel the growth of the market within China.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-wise Insights

Which is the Most Consumed Drug in the Cold, Cough and Sore Throat Remedies Market?

Antihistamines Remain the Highly Sought-After Drug in the Market”

As per FMI, antihistamines segment held the largest value share of around 26.8% in the global cold, cough and sore throat remedies market in 2021 and is poised to grow at a higher CAGR during the forecast period. This can be attributed to the rising consumption of antihistamines for treating allergic rhinitis, common cold, influenza and various other diseases. Patients usually take antihistamines as an inexpensive, generic drug that can be bought without a prescription and provides relief from various allergies and other medical conditions.

Adults who have a common cold may benefit from antihistamine combinations with decongestants and/or analgesics, and first-generation antihistamines can lessen symptoms like sneezing, rhinorrhoea, nasal mucus, and, occasionally, cough. In the global market for cold, cough, and sore throat remedies, this segment consequently holds a leading market share value.

What Doses of Cold, Cough and Sore Throat Remedies are Largely in Focus Globally?

“Oral Syrups Remain Highly Popular Doses Among Masses”

Oral syrups segment held the largest revenue share of about 33.3% of the global cold, cough and sore throat remedies market in 2021 and is expected to display a gradual growth over the forecast period, with an estimated market share value of 32.2% in 2032.

The segment holds a greater market share, as oral syrups as medication doses for the management of cold, cough and sore throat are frequently prescribed for paediatric patients, as well as the elderly, as the formulation has displayed greater patient compliance to treatment.

Which Distribution Channel Contributes Most to the Global Cold, Cough and Sore Throat Remedies Market?

“Drugs Stores to Generate Maximum Revenues in the Global Market”

As per FMI, drug stores held the highest market share value of about 38.0% in 2021 and iis expected to retain its dominance even during the forecast period. The availability of a vast range of OTC medications for cold, cough and sore throat, low-cost medication, as well as greater accessibility to treatment, are factors driving the growth of this segment within the global cold, cough and sore throat remedies market.

Competitive Landscape

With several competitors in cold, cough and sore throat remedies, the overall market is highly fragmented. Key players are undergoing strategic measures for growth through acquisitions and collaboration, as well as new product launches.

Some of the recent developments in cold, cough and sore throat remedies market are given below:

  • The sales of Reckitt Benckiser Group PLC's over-the-counter goods increased by 20% in October 2021, primarily due to Mucinex, and the company's cold and flu brands gained market share.
  • In October 2020, Novartis and Molecular Partners announced a partnership to develop two DARPin® treatments that may be used to combat COVID-19, a virus that causes fever, chills, a sore throat, fatigue, poor energy, headaches, and muscular and body aches.
  • In 2021, Dexa Medica, a leading multinational pharmaceutical company, launched a very effective and highly recommended cold and cough brand named Konos.

In 2020, Applied Biological Laboratories launched Biovanta, the only 100% natural, safe, and effective OTC drug for cough, cold and sore throat.

Report Scope as per Cold, Cough and Sore Throat Remedies Industry Analysis

Attribute

Details

Estimated Market Size (2022)

US$ 39.9 Bn

Projected Market Size (2032)

US$ 37.7 Bn

Anticipated Growth Rate (2022-2032)

0.6%

Forecast Period

2015-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, North Africa, and South Africa

Key Market Segments Covered

Drug, Doses, Distribution Channel, and Region

Key Companies Profiled

  • Reckitt Benckiser Group PLC
  • Johnson & Johnson Services, Inc.
  • GlaxoSmithKline plc.
  • Novartis AG
  • Bayer AG
  • AstraZeneca plc.
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Prestige Brands Holdings, Inc.
  • Procter & Gamble Co.

Report Coverage

Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Key Market Segments Covered in Cold, Cough and Sore Throat Remedies Industry Research

By Drug:

  • Antihistamines
  • Expectorants
  • Bronchodilators
  • Decongestants
  • Antibiotics
  • Others

By Doses:

  • Oral Syrups
  • Tablets/Pills
  • Nasal Drops
  • Lozenges
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • E-Commerce/Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global cold, cough and sore throat remedies market was valued at around US$ 38.7 Bn in 2021 and is expected to reach US$ 39.9 Bn in 2022.

Sales of cold, cough and sore throat remedies are set to witness a CAGR of 0.6% between 2022 and 2032, totaling a valuation of around US$ 37.7 Bn by 2032.

Demand for cold, cough and sore throat remedies market increased at 3.0% CAGR from 2015 to 2021.

The U.S., China, Germany, Japan, and Italy are the most lucrative markets for cold, cough and sore throat remedies, currently holding around 61.7% market share of the global market.

The U.S. accounted for around 95.4% share of the North American cold, cough and sore throat remedies market in 2021.

Johnson & Johnson Services, Inc., GlaxoSmithKline plc, and Novartis AG, are the top three manufacturers of cold, cough, and sore throat remedies.

The China market held a share of about 21.7% in the global cold, cough and sore throat remedies market in 2021.

In 2021, India held a share of about 2.7% in the global cold, cough and sore throat remedies market.

The German cold, cough and sore throat remedies market is expected to gain traction at a CAGR of 0.1% through the forecast years.

The key players within the cold, cough and sore throat remedies market space include Reckitt Benckiser Group PLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, AstraZeneca plc., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Prestige Brands Holdings, Inc., and Procter & Gamble Co.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Promotional Strategies, By Key Manufacturers

    4.2. Key Regulations

    4.3. Value Chain Analysis

    4.4. PESTEL Analysis

    4.5. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Antibiotics Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing Geriatric Age Group Population

        5.2.2. New Product Launch

        5.2.3. Product Adoption Rate

        5.2.4. Growing R&D Activities

        5.2.5. Prevalence of Viral Respiratory Tract Infections

        5.2.6. Growing Demand for Nasal Formulations for Cold

        5.2.7. Product Penetration

        5.2.8. Affordability of OTC Drugs

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Drug

        6.1.2. By Dose

        6.1.3. By Distribution Channel

        6.1.4. By Country

    6.2. 2021 Market Scenario

7. Global Cold, Cough, and Sore Throat Remedies Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Drug

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Cold, Cough and Sore Throat Remedies Market Demand (in Value or Size in US$ Mn) Analysis 2015–2021 and Forecast, 2022–2032

    8.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    8.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Cold, Cough and Sore Throat Remedies Market Analysis 2015-2021 and Forecast 2022–2032, By Drug

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Drug, 2015 - 2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug, 2022 - 2032

        9.3.1. Antihistamines

        9.3.2. Expectorants

        9.3.3. Bronchodilators

        9.3.4. Decongestants

        9.3.5. Antibiotics

        9.3.6. Others

    9.4. Market Attractiveness Analysis By Drug

10. Global Cold, Cough and Sore Throat Remedies Market Analysis 2015-2021 and Forecast 2022–2032, By Dose

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Dose , 2015 - 2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Dose, 2022 - 2032

        10.3.1. Oral Syrups

        10.3.2. Tablets/Pills

        10.3.3. Nasal Drops

        10.3.4. Lozenges

        10.3.5. Others

    10.4. Market Attractiveness Analysis By Dose

11. Global Cold, Cough and Sore Throat Remedies Market Analysis 2015-2021 and Forecast 2022–2032, By Distribution Channel

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015 - 2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Drug Stores

        11.3.4. Supermarkets/Hypermarkets

        11.3.5. e-Commerce/Online Pharmacies

    11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Cold, Cough and Sore Throat Remedies Market Analysis 2015-2021 and Forecast 2022–2032, By Region

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa

    12.4. Market Attractiveness Analysis By Region

13. North America Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

    13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Drug

        13.3.3. By Dose

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Drug

        13.4.3. By Dose

        13.4.4. By Distribution Channel

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. U.S. Cold, Cough and Sore Throat Remedies Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast By Market Taxonomy

                13.8.1.2.1. By Country

                13.8.1.2.2. By Drug

                13.8.1.2.3. By Dose

                13.8.1.2.4. By Distribution Channel

        13.8.2. Canada Cold, Cough and Sore Throat Remedies Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast By Market Taxonomy

                13.8.2.2.1. By Country

                13.8.2.2.2. By Drug

                13.8.2.2.3. By Dose

                13.8.2.2.4. By Distribution Channel

14. Latin America Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

    14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        14.3.1. By Country

            14.3.1.1. Mexico

            14.3.1.2. Brazil

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

                14.3.1.4.1. By Country

                14.3.1.4.2. By Drug

                14.3.1.4.3. By Dose

                14.3.1.4.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

                14.4.1.1.1. By Country

                14.4.1.1.2. By Drug

                14.4.1.1.3. By Dose

                14.4.1.1.4. By Distribution Channel

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. Mexico Cold, Cough and Sore Throat Remedies Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast By Market Taxonomy

                14.8.1.2.1. By Drug

                14.8.1.2.2. By Dose

                14.8.1.2.3. By Distribution Channel

        14.8.2. Brazil Cold, Cough and Sore Throat Remedies Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast By Market Taxonomy

                14.8.2.2.1. By Country

                14.8.2.2.2. By Drug

                14.8.2.2.3. By Dose

                14.8.2.2.4. By Distribution Channel

        14.8.3. Argentina Cold, Cough and Sore Throat Remedies Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast By Market Taxonomy

                14.8.3.2.1. By Drug

                14.8.3.2.2. By Dose

                14.8.3.2.3. By Distribution Channel

15. Europe Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

    15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Drug

        15.3.3. By Dose

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Drug

        15.4.3. By Dose

        15.4.4. By Distribution Channel

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. Germany Cold, Cough and Sore Throat Remedies Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast By Market Taxonomy

                15.8.1.2.1. By Drug

                15.8.1.2.2. By Dose

                15.8.1.2.3. By Distribution Channel

        15.8.2. Italy Cold, Cough and Sore Throat Remedies Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast By Market Taxonomy

                15.8.2.2.1. By Drug

                15.8.2.2.2. By Dose

                15.8.2.2.3. By Distribution Channel

        15.8.3. France Cold, Cough and Sore Throat Remedies Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast By Market Taxonomy

                15.8.3.2.1. By Drug

                15.8.3.2.2. By Dose

                15.8.3.2.3. By Distribution Channel

        15.8.4. U.K. Cold, Cough and Sore Throat Remedies Market Analysis

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast By Market Taxonomy

                15.8.4.2.1. By Drug

                15.8.4.2.2. By Dose

                15.8.4.2.3. By Distribution Channel

        15.8.5. Spain Cold, Cough and Sore Throat Remedies Market Analysis

            15.8.5.1. Introduction

            15.8.5.2. Market Analysis and Forecast By Market Taxonomy

                15.8.5.2.1. By Drug

                15.8.5.2.2. By Dose

                15.8.5.2.3. By Distribution Channel

        15.8.6. BENELUX Cold, Cough and Sore Throat Remedies Market Analysis

            15.8.6.1. Introduction

            15.8.6.2. Market Analysis and Forecast By Market Taxonomy

                15.8.6.2.1. By Drug

                15.8.6.2.2. By Dose

                15.8.6.2.3. By Distribution Channel

        15.8.7. Russia Cold, Cough and Sore Throat Remedies Market Analysis

            15.8.7.1. Introduction

            15.8.7.2. Market Analysis and Forecast By Market Taxonomy

                15.8.7.2.1. By Drug

                15.8.7.2.2. By Dose

                15.8.7.2.3. By Distribution Channel

16. East Asia Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

    16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Drug

        16.3.3. By Dose

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Drug

        16.4.3. By Dose

        16.4.4. By Distribution Channel

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. China Cold, Cough and Sore Throat Remedies Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast By Market Taxonomy

                16.8.1.2.1. By Drug

                16.8.1.2.2. By Dose

                16.8.1.2.3. By Distribution Channel

        16.8.2. Japan Cold, Cough and Sore Throat Remedies Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast By Market Taxonomy

                16.8.2.2.1. By Drug

                16.8.2.2.2. By Dose

                16.8.2.2.3. By Distribution Channel

        16.8.3. South Korea Cold, Cough and Sore Throat Remedies Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast By Market Taxonomy

                16.8.3.2.1. By Drug

                16.8.3.2.2. By Dose

                16.8.3.2.3. By Distribution Channel

17. South Asia Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

    17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Malaysia

            17.3.1.4. Thailand

            17.3.1.5. Rest of South Asia

        17.3.2. By Drug

        17.3.3. By Dose

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Drug

        17.4.3. By Dose

        17.4.4. By Distribution Channel

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. India Cold, Cough and Sore Throat Remedies Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast By Market Taxonomy

                17.8.1.2.1. By Drug

                17.8.1.2.2. By Dose

                17.8.1.2.3. By Distribution Channel

        17.8.2. Indonesia Cold, Cough and Sore Throat Remedies Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast By Market Taxonomy

                17.8.2.2.1. By Drug

                17.8.2.2.2. By Dose

                17.8.2.2.3. By Distribution Channel

        17.8.3. Malaysia Cold, Cough and Sore Throat Remedies Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast By Market Taxonomy

                17.8.3.2.1. By Drug

                17.8.3.2.2. By Dose

                17.8.3.2.3. By Distribution Channel

        17.8.4. Thailand Cold, Cough and Sore Throat Remedies Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast By Market Taxonomy

                17.8.4.2.1. By Drug

                17.8.4.2.2. By Dose

                17.8.4.2.3. By Distribution Channel

18. Oceania Cold, Cough and Sore Throat Remedies Market 2015-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

    18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Drug

        18.3.3. By Dose

        18.3.4. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Drug

        18.4.3. By Dose

        18.4.4. By Distribution Channel

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Country Level Analysis & Forecast

        18.7.1. Australia Cold, Cough and Sore Throat Remedies Market Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast By Market Taxonomy

                18.7.1.2.1. By Drug

                18.7.1.2.2. By Dose

                18.7.1.2.3. By Distribution Channel

        18.7.2. New Zealand Cold, Cough and Sore Throat Remedies Market Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast By Market Taxonomy

                18.7.2.2.1. By Drug

                18.7.2.2.2. By Dose

                18.7.2.2.3. By Distribution Channel

19. Middle East and Africa (MEA) Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

    19.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Turkey

            19.3.1.3. South Africa

            19.3.1.4. North Africa

            19.3.1.5. Rest of Middle East and Africa

        19.3.2. By Drug

        19.3.3. By Dose

        19.3.4. By Distribution Channel

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Drug

        19.4.3. By Dose

        19.4.4. By Distribution Channel

    19.5. Market Trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. GCC Countries Cold, Cough and Sore Throat Remedies Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast By Market Taxonomy

                19.8.1.2.1. By Drug

                19.8.1.2.2. By Dose

                19.8.1.2.3. By Distribution Channel

        19.8.2. Turkey Cold, Cough and Sore Throat Remedies Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast By Market Taxonomy

                19.8.2.2.1. By Drug

                19.8.2.2.2. By Dose

                19.8.2.2.3. By Distribution Channel

        19.8.3. South Africa Cold, Cough and Sore Throat Remedies Market Analysis

            19.8.3.1. Introduction

            19.8.3.2. Market Analysis and Forecast By Market Taxonomy

                19.8.3.2.1. By Drug

                19.8.3.2.2. By Dose

                19.8.3.2.3. By Distribution Channel

        19.8.4. North Africa Cold, Cough and Sore Throat Remedies Market Analysis

            19.8.4.1. Introduction

            19.8.4.2. Market Analysis and Forecast By Market Taxonomy

                19.8.4.2.1. By Drug

                19.8.4.2.2. By Dose

                19.8.4.2.3. By Distribution Channel

20. Market Structure Analysis

    20.1. Market Analysis By Tier of Companies

    20.2. Market Concentration

    20.3. Market Share Analysis (%) of Top Players

    20.4. Market Presence Analysis

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. Reckitt Benckiser Group PLC

            21.3.1.1. Overview

            21.3.1.2. Drug Portfolio

            21.3.1.3. Sales Footprint

            21.3.1.4. Key Financials

            21.3.1.5. SWOT Analysis

            21.3.1.6. Strategic Overview

        21.3.2. Johnson & Johnson Services, Inc.

            21.3.2.1. Overview

            21.3.2.2. Drug Portfolio

            21.3.2.3. Sales Footprint

            21.3.2.4. Key Financials

            21.3.2.5. SWOT Analysis

            21.3.2.6. Strategic Overview

        21.3.3. GlaxoSmithKline plc.

            21.3.3.1. Overview

            21.3.3.2. Drug Portfolio

            21.3.3.3. Sales Footprint

            21.3.3.4. Key Financials

            21.3.3.5. SWOT Analysis

            21.3.3.6. Strategic Overview

        21.3.4. Novartis AG

            21.3.4.1. Overview

            21.3.4.2. Drug Portfolio

            21.3.4.3. Sales Footprint

            21.3.4.4. Key Financials

            21.3.4.5. SWOT Analysis

            21.3.4.6. Strategic Overview

        21.3.5. Bayer AG

            21.3.5.1. Overview

            21.3.5.2. Drug Portfolio

            21.3.5.3. Sales Footprint

            21.3.5.4. Key Financials

            21.3.5.5. SWOT Analysis

            21.3.5.6. Strategic Overview

        21.3.6. AstraZeneca plc.

            21.3.6.1. Overview

            21.3.6.2. Drug Portfolio

            21.3.6.3. Sales Footprint

            21.3.6.4. Key Financials

            21.3.6.5. SWOT Analysis

            21.3.6.6. Strategic Overview

        21.3.7. Sun Pharmaceutical Industries Ltd.

            21.3.7.1. Overview

            21.3.7.2. Drug Portfolio

            21.3.7.3. Sales Footprint

            21.3.7.4. Key Financials

            21.3.7.5. SWOT Analysis

            21.3.7.6. Strategic Overview

        21.3.8. Pfizer Inc.

            21.3.8.1. Overview

            21.3.8.2. Drug Portfolio

            21.3.8.3. Sales Footprint

            21.3.8.4. Key Financials

            21.3.8.5. SWOT Analysis

            21.3.8.6. Strategic Overview

        21.3.9. Prestige Brands Holdings, Inc.

            21.3.9.1. Overview

            21.3.9.2. Drug Portfolio

            21.3.9.3. Sales Footprint

            21.3.9.4. Key Financials

            21.3.9.5. SWOT Analysis

            21.3.9.6. Strategic Overview

        21.3.10. Procter & Gamble Co.

            21.3.10.1. Overview

            21.3.10.2. Drug Portfolio

            21.3.10.3. Sales Footprint

            21.3.10.4. Key Financials

            21.3.10.5. SWOT Analysis

            21.3.10.6. Strategic Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032, by Drug

Table 02: Global Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032by Dose

Table 03: Global Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032, by Distribution Channel

Table 04: Global Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032, by Region

Table 05: North America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Country

Table 06: North America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Drug

Table 07: North America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Dose

Table 08: North America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Distribution Channel

Table 09: Latin America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Country

Table 10: Latin America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Drug

Table 11: Latin America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Dose

Table 12: Latin America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Distribution Channel

Table 13: Europe Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Country

Table 14: Europe Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Drug

Table 15: Europe Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032by Dose

Table 16: Europe Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Distribution Channel

Table 17: East Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Country

Table 18: East Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Drug

Table 19: East Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Dose

Table 20: East Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Distribution Channel

Table 21: South Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Country

Table 22: South Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Drug

Table 23: South Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Dose

Table 24: South Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Distribution Channel

Table 25: Oceania Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Country

Table 26: Oceania Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Drug

Table 27: Oceania Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032 by Dose

Table 28: Oceania Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Distribution Channel

Table 29: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Country

Table 30: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Drug

Table 31: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Analysis 2015–2021 and Forecast 2022–2032 by Dose

Table 32: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2032, by Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis, 2015–2021

Figure 02: Global Cold, Cough and Sore Throat Remedies Market Forecast & Y-o-Y Growth, 2022–2032

Figure 03: Global Cold, Cough and Sore Throat Remedies Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032

Figure 04: Global Cold, Cough and Sore Throat Remedies Market Value Share (%) Analysis 2022 and 2032, by Drug

Figure 05: Global Cold, Cough and Sore Throat Remedies Market Y-o-Y Growth (%) Analysis 2021-2032, by Drug

Figure 06: Global Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis 2022–2032, by Drug

Figure 07: Global Cold, Cough and Sore Throat Remedies Market Value Share (%) Analysis 2022 and 2032, by Dose

Figure 08: Global Cold, Cough and Sore Throat Remedies Market Y-o-Y Growth (%) Analysis 2021-2032, by Dose

Figure 09: Global Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis 2022–2032, by Dose

Figure 10: Global Cold, Cough and Sore Throat Remedies Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel

Figure 11: Global Cold, Cough and Sore Throat Remedies Market Y-o-Y Growth (%) Analysis 2021-2032, by Distribution Channel

Figure 12: Global Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis 2022–2032, by Distribution Channel

Figure 13: Global Cold, Cough and Sore Throat Remedies Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 14: Global Cold, Cough and Sore Throat Remedies Market Y-o-Y Growth (%) Analysis 2021-2032, by Region

Figure 15: Global Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis 2022–2032, by Region

Figure 16: North America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis, 2015–2021

Figure 17: North America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Forecast, 2022-2032

Figure 18: North America Cold, Cough and Sore Throat Remedies Market Value Share, by Drug (2022 E)

Figure 19: North America Cold, Cough and Sore Throat Remedies Market Value Share, by Dose (2022 E)

Figure 20: North America Cold, Cough and Sore Throat Remedies Market Value Share, by Distribution Channel (2022 E)

Figure 21: North America Cold, Cough and Sore Throat Remedies Market Value Share, by Country (2022 E)

Figure 22: North America Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Drug, 2022–2032

Figure 23: North America Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Dose, 2022–2032

Figure 24: North America Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 25: North America Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Country, 2022–2032

Figure 26: U.S. Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 27: Global Vs. U.S. Growth Comparison

Figure 28: U.S. Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 29: U.S. Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 30: U.S. Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 31: Canada Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 32: Global Vs. Canada. Growth Comparison

Figure 33: Canada Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 34: Canada Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 35: Canada Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 36: Latin America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis, 2015–2021

Figure 37: Latin America Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Forecast, 2022-2032

Figure 38: Latin America Cold, Cough and Sore Throat Remedies Market Value Share, by Drug (2022 E)

Figure 39: Latin America Cold, Cough and Sore Throat Remedies Market Value Share, by Dose (2022 E)

Figure 40: Latin America Cold, Cough and Sore Throat Remedies Market Value Share, by Distribution Channel (2022 E)

Figure 41: Latin America Cold, Cough and Sore Throat Remedies Market Value Share, by Country (2022 E)

Figure 42: Latin America Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Drug, 2022–2032

Figure 43: Latin America Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Dose, 2022–2032

Figure 44: Latin America Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 45: Latin America Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Country, 2022–2032

Figure 46: Mexico Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 47: Global Vs Mexico Growth Comparison

Figure 48: Mexico Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 49: Mexico Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 50: Mexico Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 51: Brazil Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 52: Global Vs. Brazil. Growth Comparison

Figure 53: Brazil Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 54: Brazil Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 55: Brazil Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 56: Argentina Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 57: Global Vs Argentina Growth Comparison

Figure 58: Argentina Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 59: Argentina Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 60: Argentina Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 61: Europe Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis, 2015–2021

Figure 62: Europe Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Forecast, 2022-2032

Figure 63: Europe Cold, Cough and Sore Throat Remedies Market Value Share, by Drug (2022 E)

Figure 64: Europe Cold, Cough and Sore Throat Remedies Market Value Share, by Dose (2022 E)

Figure 65: Europe Cold, Cough and Sore Throat Remedies Market Value Share, by Distribution Channel (2022 E)

Figure 66: Europe Cold, Cough and Sore Throat Remedies Market Value Share, by Country (2022 E)

Figure 67: Europe Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Drug, 2022–2032

Figure 68: Europe Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Dose, 2022–2032

Figure 69: Europe Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 70: Europe Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Country, 2022–2032

Figure 71: UK Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 72: Global Vs. UK Growth Comparison

Figure 73: UK Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 74: UK Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 75: UK Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 76: Germany Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 77: Global Vs. Germany Growth Comparison

Figure 78: Germany Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 79: Germany Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 80: Germany Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 81: Italy Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 82: Global Vs. Italy Growth Comparison

Figure 83: Italy Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 84: Italy Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 85: Italy Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 86: France Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 87: Global Vs France Growth Comparison

Figure 88: France Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 89: France Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 90: France Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 91: Spain Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 92: Global Vs Spain Growth Comparison

Figure 93: Spain Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 94: Spain Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 95: Spain Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 96: Russia Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 97: Global Vs Russia Growth Comparison

Figure 98: Russia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 99: Russia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 100: Russia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 101: BENELUX Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 102: Global Vs BENELUX Growth Comparison

Figure 103: BENELUX Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 104: BENELUX Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 105: BENELUX Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 106: East Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis, 2015–2021

Figure 107: East Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Forecast, 2022-2032

Figure 108: East Asia Cold, Cough and Sore Throat Remedies Market Value Share, by Drug (2022 E)

Figure 109: East Asia Cold, Cough and Sore Throat Remedies Market Value Share, by Dose (2022 E)

Figure 110: East Asia Cold, Cough and Sore Throat Remedies Market Value Share, by Distribution Channel (2022 E)

Figure 111: East Asia Cold, Cough and Sore Throat Remedies Market Value Share, by Country (2022 E)

Figure 112: East Asia Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Drug, 2022–2032

Figure 113: East Asia Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Dose, 2022–2032

Figure 114: East Asia Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 115: East Asia Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Country, 2022–2032

Figure 116: China Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 117: Global Vs. China Growth Comparison

Figure 118: China Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 119: China Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 120: China Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 121: Japan Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 122: Global Vs. Japan Growth Comparison

Figure 123: Japan Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 124: Japan Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 125: Japan Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 126: South Korea Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 127: Global Vs South Korea Growth Comparison

Figure 128: South Korea Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 129: South Korea Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 130: South Korea Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 131: South Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis, 2015–2021

Figure 132: South Asia Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Forecast, 2022-2032

Figure 133: South Asia Cold, Cough and Sore Throat Remedies Market Value Share, by Drug (2022 E)

Figure 134: South Asia Cold, Cough and Sore Throat Remedies Market Value Share, by Dose (2022 E)

Figure 135: South Asia Cold, Cough and Sore Throat Remedies Market Value Share, by Distribution Channel (2022 E)

Figure 136: South Asia Cold, Cough and Sore Throat Remedies Market Value Share, by Country (2022 E)

Figure 137: South Asia Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Drug, 2022–2032

Figure 138: South Asia Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Dose, 2022–2032

Figure 139: South Asia Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 140: South Asia Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Country, 2022–2032

Figure 141: India Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 142: Global Vs. India Growth Comparison

Figure 143: India Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 144: India Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 145: India Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 146: Indonesia Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 147: Global Vs. Indonesia Growth Comparison

Figure 148: Indonesia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 149: Indonesia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 150: Indonesia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 151: Malaysia Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 152: Global Vs. Malaysia Growth Comparison

Figure 153: Malaysia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 154: Malaysia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 155: Malaysia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 156: Thailand Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 157: Global Vs. Thailand Growth Comparison

Figure 158: Thailand Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 159: Thailand Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 160: Thailand Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 161: Oceania Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis, 2015–2021

Figure 162: Oceania Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Forecast, 2022-2032

Figure 163: Oceania Cold, Cough and Sore Throat Remedies Market Value Share, by Drug (2022 E)

Figure 164: Oceania Cold, Cough and Sore Throat Remedies Market Value Share, by Dose (2022 E)

Figure 165: Oceania Cold, Cough and Sore Throat Remedies Market Value Share, by Distribution Channel (2022 E)

Figure 166: Oceania Cold, Cough and Sore Throat Remedies Market Value Share, by Country (2022 E)

Figure 167: Oceania Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Drug, 2022–2032

Figure 168: Oceania Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Dose, 2022–2032

Figure 169: Oceania Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 170: Oceania Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Country, 2022–2032

Figure 171: Australia Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 172: Global Vs. Australia Growth Comparison

Figure 173: Australia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 174: Australia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 175: Australia Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 176: New Zealand Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 177: Global Vs New Zealand Growth Comparison

Figure 178: New Zealand Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 179: New Zealand Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 180: New Zealand Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 181: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Analysis, 2015–2021

Figure 182: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Value (US$ Mn) Forecast, 2022-2032

Figure 183: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Value Share, by Drug (2022 E)

Figure 184: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Value Share, by Dose (2022 E)

Figure 185: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Value Share, by Distribution Channel (2022 E)

Figure 186: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Value Share, by Country (2022 E)

Figure 187: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Drug, 2022–2032

Figure 188: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Dose, 2022–2032

Figure 189: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 190: Middle East & Africa Cold, Cough and Sore Throat Remedies Market Attractiveness Analysis by Country, 2022–2032

Figure 191: GCC Countries Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 192: Global Vs GCC Countries Growth Comparison

Figure 193: GCC Countries Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 194: GCC Countries Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 195: GCC Countries Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 196: Turkey Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 197: Global Vs. Turkey Growth Comparison

Figure 198: Turkey Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 199: Turkey Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 200: Turkey Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 201: South Africa Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 202: Global Vs. South Africa Growth Comparison

Figure 203: South Africa Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 204: South Africa Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 205: South Africa Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 206: North Africa Cold, Cough and Sore Throat Remedies Market Value Proportion Analysis, 2021

Figure 207: Global Vs North Africa Growth Comparison

Figure 208: North Africa Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Drug, 2021 & 2032

Figure 209: North Africa Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Dose, 2021 & 2032

Figure 210: North Africa Cold, Cough and Sore Throat Remedies Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Strep Throat Treatment Market

Published : July 2020

Healthcare

Respiratory Pathogen Testing Kits Market

Published : June 2020

Healthcare

Analgesics Market

Published : December 2021

Healthcare

Respiratory Inhaler Devices Market

Published : January 2021

Google translate

Cold, Cough and Sore Throat Remedies Market